Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translocation t(11;18)(q21;q21) in gastric B-cell lymphomas.

Cancer science·2009
Same author

Mycobacterium avium subspecies paratuberculosis and Crohn's disease granulomas.

Scandinavian journal of gastroenterology·2008
Same author

Chromoendoscopy points the way to understanding recovery of gastric function after Helicobacter pylori eradication.

Gastrointestinal endoscopy·2006
Same author

Co-localization of TFF2 with gland mucous cell mucin in gastric mucous cells and in extracellular mucous gel adherent to normal and damaged gastric mucosa.

Histochemistry and cell biology·2006
Same author

Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2006
Same author

Interobserver variation in the histopathological assessment of malt/malt lymphoma: towards a consensus.

Blood cells, molecules & diseases·2004

Related Experiment Videos

Gastric atrophy, diagnosing and staging.

Hala M T El-Zimaity

    World Journal of Gastroenterology
    |September 29, 2006
    PubMed
    Summary

    Helicobacter pylori (H. pylori) causes gastritis and related diseases. Atrophy patterns, not intestinal metaplasia subtypes, predict pre-malignant potential, highlighting the need for better markers.

    Area of Science:

    • Gastroenterology and Pathology
    • Microbiology and Immunology

    Background:

    • Helicobacter pylori (H. pylori) is the established cause of gastritis and associated pathologies, including peptic ulcers, gastric cancer, and MALT lymphoma.
    • The progression of H. pylori gastritis involves inflammation spreading from the antrum to the corpus, leading to atrophic changes, reduced acid secretion, and parietal cell loss.

    Discussion:

    • Subtyping intestinal metaplasia offers no significant clinical value for patients, pathologists, or endoscopists.
    • The extent and severity of atrophy, with or without intestinal metaplasia, are more critical indicators of disease progression than the subtype of intestinal metaplasia.

    Key Insights:

    • Atrophy patterns in H. pylori gastritis are more clinically relevant than intestinal metaplasia subtypes.
    • Identifying reliable biomarkers for pre-malignant potential in H. pylori-associated gastritis remains a critical challenge.

    Related Experiment Videos

    Outlook:

    • Future research should focus on developing and validating novel markers to predict the malignant potential of H. pylori gastritis.
    • Improved understanding of atrophic gastritis progression may lead to more targeted surveillance and treatment strategies.